RBM rescinds 510(k) withdrawal

Following discussions with the FDA, Response Biomedical (CDNX:RBM) said it has rescinded its voluntary withdrawal of a 510(k) submission for its Rapid Antigen Measurement Platform (RAMP) Reader and wh...